Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
54,486,781
-
Total 13F shares
-
30,483,833
-
Share change
-
+472,194
-
Total reported value
-
$1,004,416,909
-
Price per share
-
$32.95
-
Number of holders
-
178
-
Value change
-
+$19,758,700
-
Number of buys
-
100
-
Number of sells
-
78
Institutional Holders of Emergent BioSolutions Inc. - Common Stock (EBS) as of Q2 2015
As of 30 Jun 2015,
Emergent BioSolutions Inc. - Common Stock (EBS) was held by
178 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,483,833 shares.
The largest 10 holders included
Bank of New York Mellon Corp, VANGUARD GROUP INC, Broadfin Capital, LLC, BlackRock Fund Advisors, DIMENSIONAL FUND ADVISORS LP, STATE STREET CORP, BlackRock Institutional Trust Company, N.A., LOOMIS SAYLES & CO L P, FIDUCIARY MANAGEMENT ASSOCIATES LLC, and GLENMEDE TRUST CO NA.
This page lists
178
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.